Read more from the original source: Umoja Biopharma to Present at the 2023 Cell & Gene Meeting on the Mesa
Read more from the original source: Umoja Biopharma to Present at the 2023 Cell & Gene Meeting on the Mesa
Original post: T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023
See original here: Oncternal Therapeutics Announces First Patient Dosed in Phase 1/2 Study of Dual-Action AR Inhibitor, ONCT-534, in Patients with Metastatic...
See the article here: ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
Continued here: Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023
Originally posted here: Athira Pharma Presents Preclinical Data Further Supporting the Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
Originally posted here: Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
Go here to see the original: Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023
See the original post: Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Link: Centessa Pharmaceuticals Announces Additions to Senior Leadership Team
Recent Comments